منتديات جناب الهضب

جدارة ، موقع نور ، برنامج نور ، جداره ، النتائج ،حافز ، قياس ،نتائج الطلاب ، نتائج الطالبات ، نتائج القدرات ، اسماء المرشحات ، دفعات جدارة ، أخر أخبار جدارة،نتائج القدرات ، نتائج التحصيلي ، جناب الهضب التعليمي ، موهبة ،كفايات

اعلانات قوقل متجاوبة2

صحيفة حزم

صحيفة حزم المالك ورئيس التحرير مرعي بن علي القحطاني http://www.alhzim.com/index.php

    Delayed Hypersensitivity Reactions ,Background,History,LaboratoryStudies,,treatment,MedicationSummary

    شاطر

    الفريق السعودي4
    مستشار منتديات جناب الهضب
    مستشار منتديات جناب الهضب

    عدد المساهمات : 762
    العمر : 24

    Delayed Hypersensitivity Reactions ,Background,History,LaboratoryStudies,,treatment,MedicationSummary

    مُساهمة من طرف الفريق السعودي4 في الخميس 5 يوليو 2012 - 7:03

    Delayed Hypersensitivity Reactions ,Background,History,LaboratoryStudies,,treatment,Medication Summary


    E. Medicine Click here


    Background

    Delayed hypersensitivity reactions are inflammatory reactions initiated by mononuclear leukocytes. The term delayed is used to differentiate a secondary cellular response, which appears 48-72 hours after antigen exposure, from an immediate hypersensitivity response, which generally appears within 12 minutes of an antigen challenge. These reactions are mediated by T cells and monocytes/macrophages rather than by antibodies. They are also termed type IV hypersensitivity reactions.

    Delayed hypersensitivity is a major mechanism of defense against various intracellular pathogens, including mycobacteria, fungi, and certain parasites, and it occurs in transplant rejection and tumor immunity. The central role of CD4+ T cells in delayed hypersensitivity is illustrated in patients with AIDS. Because of the loss of CD4+ cells, the host response against intracellular pathogens such as Mycobacterium tuberculosis is markedly impaired. The bacteria are engulfed by macrophages but are not killed.

    If T-cell function is abnormal, the patient presents with opportunistic infections, including infection with mycobacteria, fungi, parasites, and, often, mucocutaneous candidiasis. Undesirable consequences of delayed-type hypersensitivity (DTH) reactions include illness such as contact dermatitis and allograft rejection. Examples of DTH reactions are contact dermatitis (eg, poison ivy rash), tuberculin skin test reactions, granulomatous inflammation (eg, sarcoidosis, Crohn disease), allograft rejection, graft versus host disease, and autoimmune hypersensitivity reactions. Of note, the Rhus genus of plants, which includes poison ivy, poison oak, and poison sumac, all cause identical rashes.

    History


    The clinical history of delayed hypersensitivity reactions differs depending on the etiology. Some of the more common examples are as follows:

    Contact hypersensitivity (ie, allergic contact dermatitis)
    Patients often report being in wooded areas or having made contact with poison ivy or poison oak, which caused a rash, itching, or both.

    The exposure occurs 48-72 hours before the development of symptoms.

    Tuberculin hypersensitivity reactions
    Many times during a routine health screening, patients have a positive Mantoux test result and are asymptomatic. In these cases, patients may recall being exposed to someone with TB or with a chronic cough. In many cases, patients do not recall a possible exposure.

    The Mantoux test itself is a delayed hypersensitivity reaction.[1] Thus, 48-72 hours following the intradermal administration of purified M tuberculosis protein derivative, patients who have been exposed to the bacteria develop a delayed hypersensitivity reaction manifested by inflammation and edema in the dermis.[2]

    Granulomatous hypersensitivity reactions
    Diseases in which delayed hypersensitivity is the major pathophysiological response include tuberculous leprosy, TB, sarcoidosis, and schistosomiasis.


    Laboratory Studies


    Contact dermatitis
    No specific laboratory tests are needed unless the diagnosis is uncertain. Contact dermatitis is a clinical diagnosis. A skin biopsy can be performed if the diagnosis is in question, and the results of patch tests are often helpful to determine the specific contactant.

    Tuberculin hypersensitivity skin reaction
    No laboratory tests are needed. This is a specific local reaction to an administered Mantoux test.

    Granulomatous diseases
    Diagnostic testing differs depending on the disease suggested.

    If TB is considered, a Mantoux test and a chest radiograph should be performed.[3, 4]

    If sarcoidosis is suggested, a chest radiograph and, if indicated, a biopsy, should be performed. An elevated serum angiotensin-converting enzyme level is not diagnostic.

    If cutaneous lesions are possibly related to a granulomatous disease, then a skin biopsy can be performed.

    Possible cell-mediated immunity
    If a deficiency in cell-mediated immunity is suggested, an anergy battery of skin tests can be performed.[5] Typically, the antigens used are candidin, trichophytin, mumps skin test antigen, and tetanus toxoid. If fewer than 4 recall antigens are used, the likelihood of a false-negative result is increased.

    The concentrations used are candidin at 1:100 (vol:vol), trichophytin at 1:30 or 1:100 (vol:vol), mumps skin test antigen at 40 colony-forming units/mL, and tetanus toxoid at 0.2 Loeffler units/0.1 mL in 1:100 (vol:vol). The test volume is 0.1 mL placed intradermally. The maximum perpendicular diameters of induration are determined at 24, 48, and 72 hours. An immediate (20 min) wheal and flare at the injection site during a DTH skin test may result in a false-negative DTH reaction.

    The term anergy is now expanded to imply an absence of the capacity to express DTH skin test reactivity to the antigens usually encountered (so-called recall antigens). The presence of anergy depends on the number and type of antigens used in the skin test evaluation, the smallest reaction considered to be positive, and other technical factors.

    Most investigators use a panel of 4-5 antigens to which more than 90% of healthy adults exhibit at least one positive reaction. This percentage of reactors is understandably lower in healthy children because of a reduced opportunity for prior exposure to the microorganisms that normally result in such DTH reactivity.

    Generally, the highest prevalence of reactions occurs against mumps, candidal, and tetanus antigens. Relative deficits are understandably more difficult to evaluate, but they are probably more common than absolute anergy in the biologic processes and clinical disorders described.

    In some clinical situations, individuals may exhibit a deficit in expressing DTH reactions to particular antigens previously encountered, while other recall DTH responses are normal. Some controversy exists regarding whether the absence of reactivity to a tuberculin DTH skin test and normal responses to other recall antigens exclude previous or current infection with M tuberculosis. Reactivity to newly encountered antigens may not develop, but recall DTH reactivity is normal.

    In more recent studies, investigators have focused on the cellular basis of anergy. With the aid of in vitro technology, abnormalities involving multiple components of the DTH apparatus have been described. The expression of DTH skin test reactivity requires the capacity to mount a cellular inflammatory reaction, a response frequently impaired nonspecifically in persons with chronic debilitating diseases. Moreover, other T-cell–dependent functions apparently are frequently impaired. Such deficits may either play an important role in the pathogenesis of a particular disease or occur as a consequence of that disease.

    Laboratory correlate of the DTH skin test
    Reactions include lymphocyte thymidine incorporation (ie, lymphocyte proliferation or blast transformation) following nonspecific stimulation with mitogens (eg, phytohemagglutinin, concanavalin A) or antigen stimulation. The mixed lymphocyte reaction is a thymidine incorporation T-cell reaction to cell surface antigens. Cytokine production from stimulated lymphocytes also may be measured


    Medical Care


    Medical treatment is specific for the disease entity. Some common examples follow.

    Contact dermatitis: The treatment of contact dermatitis varies depending on the severity of the disease. The best advice is to avoid the offending antigen. Pharmaceutical treatment varies, including over-the-counter corticosteroid preparations, prescription corticosteroid preparations, injectable corticosteroids, oral corticosteroids, and Burow solution.
    Tuberculin hypersensitivity skin reactions: Treatment is rarely needed because this response is usually short-lived and self-limited. Topical corticosteroid preparations can be applied as needed. On rare occasions, the reaction to a delayed hypersensitivity skin test may be extreme and result in axillary lymphadenopathy and fever. Such reactions are self-limited and may be treated with an antipyretic medication such as aspirin or ibuprofen.
    Granulomatous diseases: Treatment varies greatly depending on the specific disease. Refer to the appropriate eMedicine article for a full discussion (eg, see Sarcoidosis or Crohn Disease).


    Medication Summary


    Medical treatment differs greatly depending on the specific disease entity. Only a few medications are discussed. In addition to drugs mentioned below, a drug that may augment cell-mediated immunity is cimetidine, which is an H2 receptor blocker that acts as a reverse antagonist and may augment cell-mediated immunity.[6]

    الفريق السعودي4
    مستشار منتديات جناب الهضب
    مستشار منتديات جناب الهضب

    عدد المساهمات : 762
    العمر : 24

    رد: Delayed Hypersensitivity Reactions ,Background,History,LaboratoryStudies,,treatment,MedicationSummary

    مُساهمة من طرف الفريق السعودي4 في الخميس 5 يوليو 2012 - 7:04

    3 7 2012


    _________________
    http://adf.ly/BxRoN

    للمزيد والجديد أضغط على الرابط

      الوقت/التاريخ الآن هو الإثنين 5 ديسمبر 2016 - 3:32